ArticlePloS one2026
Theileria parva in Zambia: A scoping review protocol.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThe objective of this scoping review is to examine published and unpublished literature on Theileria parva in Zambia. It will identify the scope of available literature for research prioritization.
introductionTheileria parva is the most lethal tick borne disease in Zambia due to its reportedly high morbidity and mortality in cattle. It is a focus of government interventions. It is important to understand the research that has been conducted on this parasite over the years. INCLUSION CRITERIA: The review will include all studies conducted on Theileria parva in Zambia. Government and research institute reports based on recognized laboratory diagnosis will also be included.
methodsLiterature search will be conducted in Pubmed, Scopus, Web of knowledge and Embase. Primary studies from 1920 to date will be included. Titles, abstracts and full text will be examined to determine eligibility for inclusion. Extracted data will be charted into a data extraction excel file by two independent reviewers. The results will be summarised and presented as a narrative summary, tables and charts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.